Acuitas Lighthouse News Today : Breaking News, Live Updates & Top Stories | Vimarsana

OPGN | Complete OpGen Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Akumin (NASDAQ:AKU – Get Rating) and OpGen (NASDAQ:OPGN – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, risk, valuation, profitability, analyst recommendations and institutional ownership. Volatility and Risk Akumin has a beta of -0.49, suggesting that […]

Company's 52-week low was at $1.63 Price action over last quarter: down 17.09% Company Profile OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by h...

Published: Apr 19, 2021 Collaboration with NYS Department of Health’s Wadsworth Center continues for extended six-month term until September 30, 2021 Project utilizes OpGen’s Acuitas® AMR Gene Panel and Acuitas Lighthouse® Software within digital health and precision medicine platform at multiple healthcare institutions GAITHERSBURG, Md., April 19, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc.  (Nasdaq: OPGN) announced today that its strategic collaboration with the New York State Department of Health (“DOH”) to develop a state-of-the-art solution to detect, track, and manage an...